CLINICAL TRIALS PROFILE FOR HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE

All Clinical Trials for hydrochlorothiazide; metoprolol succinate

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00642096 ↗	Factorial Study of Metoprolol Succinate TOPROL-XL (324A)	Completed	AstraZeneca	Phase 3	2003-06-01	The purpose of this research study is to determine if treatment with the combination of metoprolol succinate and hydrochlorothiazide is more effective at lowering blood pressure than treatment with either of the two drugs alone. The study will also determine which combined doses of metoprolol succinate and hydrochlorothiazide are most effective at lowering blood pressure (without unacceptable side effects), and whether it is possible to combine both drugs in a single tablet to simplify blood pressure treatment.

Clinical Trial Conditions for hydrochlorothiazide; metoprolol succinate

Condition Name

Condition Name for hydrochlorothiazide; metoprolol succinate
Intervention	Trials
High Blood Pressure (Hypertension).	1

Condition MeSH

Condition MeSH for hydrochlorothiazide; metoprolol succinate
Intervention	Trials
Hypertension	1

Clinical Trial Progress for hydrochlorothiazide; metoprolol succinate

Clinical Trial Phase

Clinical Trial Phase for hydrochlorothiazide; metoprolol succinate
Clinical Trial Phase	Trials
Phase 3	1

Clinical Trial Status

Clinical Trial Status for hydrochlorothiazide; metoprolol succinate
Clinical Trial Phase	Trials
Completed	1

Clinical Trial Sponsors for hydrochlorothiazide; metoprolol succinate

Sponsor Name

Sponsor Name for hydrochlorothiazide; metoprolol succinate
Sponsor	Trials
AstraZeneca	1

Sponsor Type

Sponsor Type for hydrochlorothiazide; metoprolol succinate
Sponsor	Trials
Industry	1